Here are relevant reports on : human-capital-management-hcm-market
-
Digital Pathology Market by Product (Scanner, Software, Storage System), Type (Human, Veterinary), Application (Teleconsultation, Training, Disease Diagnosis, Drug Discovery), End User (Pharma & Biotech, Academia, Hospitals) - Global Forecast to 2030
Global digital pathology market valued at $1.30B in 2024, reached $1.46B in 2025, and is projected to grow at a robust 13.5% CAGR, hitting $2.75B by 2030. The key driver of this growth is the mounting need for telepathology to enable pathologists to remotely view slides and interact live over distances. The other factor is integrating artificial intelligence (AI) in digital pathology systems, boosting diagnostics through automated image analysis and predictive analytics.
- Published: May 2025
- Price: $ 4950
- TOC Available:
-
Nutrigenomics Market: A boon to Human Health, Perspective by Applications and Geography - Global Trends and Forecasts up to 2017
As a result of globalization, the global population is being more health conscious. The ever increasing middleclass families also prefer the healthy diet and are more concerned towards nutrition. Thus the pioneering concept of Nutrigenomics has been boon for human health which provides a customized food which helps in optimum utilization of nutrients.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Cell Viability Assays Market by Product (MTT Assay, XTT Assay, Calcein, Resazurin, Flow Cytometry, Spectrophotometer), Cell Type (Human, Animal, Microbial), Application (Basic Research, Stem Cell, Discovery & Development) - Global Forecast to 2023
The global cell viability assays market is projected to reach USD 4.16 billion by 2023, growing at a CAGR of 8.4%. The prominent players in the cell viability assays market are Thermo Fisher Scientific (US), Bio-Rad Laboratories (US), Merck (Germany), GE Healthcare (US), BioTek Instruments (US), PerkinElmer (US), Promega Corporation (US), Biotium (US), Abcam plc (UK), Canvax (Spain), Abnova (Taiwan), G-Biosciences (US), Creative Bioarray (US), Danaher Corporation (US), and Becton, Dickinson and Company (US).
- Published: September 2018
- Price: $ 4950
- TOC Available:
-
Industrial Software Market by Type (Manufacturing Execution System, SCADA, Human Machine Interface, Robotic Software, Fault Detection and Classification, Al in manufacturing, Industrial Metrology), End-use (Process, Discrete) - Global Forecast to 2029
The global industrial software market is expected to grow from USD 21.5 billion in 2024 to USD 46.6 billion by 2029, at a compound annual growth rate (CAGR) of 16.7 % during the forecast period.The key players Siemens (Germany), Rockwell Automation (US), ABB (Switzerland), Emerson Electric Co. (US) and General Electric (US).
- Published: June 2024
- Price: $ 4950
- TOC Available:
-
SCADA Market by Component (Programmable Logic Controllers (PLCs), Remote Terminal Units (RTUs), Human-machine Interfaces (HMIs), Communication Systems, Input/Output (I/O) Devices, Sensors, Actuators, Terminal Blocks, Connectors) - Global Forecast to 2030
The global SCADA market is expected to grow from USD 12.89 billion in 2025 to USD 20.05 billion by 2030, at a compound annual growth rate (CAGR) of 9.2% during the forecast period. The Key Players Rockwell Automation (US), Schneider Electric (France), ABB (Switzerland), Siemens (Germany)and Emerson Electric Co.(US)
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Asia Pacific Human Microbiome Market by Drug & Supplement (Drugs, Probiotics, Prebiotics), Disease (Infectious, Gastrointestinal, Endocrine & Metabolic Diseases), Type (BCT/FMT, LBP), End User (Hospitals, Clinics, Long-term Care) - Forecast to 2031
The Asia Pacific Human Microbiome Market, valued at US$0.19 billion in 2024, stood at US$0.26 billion in 2025 and is projected to advance at a resilient CAGR of 31.0% from 2025 to 2031, culminating in a forecasted valuation of US$1.31 billion by the end of the period. Market growth is driven by an increasing focus on preventive and personalized health, rising adoption of microbiome-based diagnostics and therapeutic solutions, and rapid advances in next-generation sequencing, AI-enabled microbiome analytics, and regional bioinformatics capabilities.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Primary Cells Market by Type (Hematopoietic, Dermatocytes, Hepatocytes, Gastrointestinal, Lung, Renal, Heart, Musculoskeletal), Origin (Human Primary Cells, Animal Primary Cells), End User (Pharma Biotech, CROs, Academia), Region - Global Forecast to 2028
The global primary cells market, valued at US$1.5 billion in 2022, stood at US$1.7 billion in 2023 and is projected to advance at a resilient CAGR of 10.5% from 2023 to 2028, culminating in a forecasted valuation of US$2.8 billion by the end of the period. The growth of this market can be attributed to factors such as the is the growing advantages of primary human cells over cell lines, rising growth in pharmaceutical & biotechnology industries, increasing demand for monoclonal antibodies, Government investments for cell-based research, and increasing cancer research.
- Published: July 2023
- Price: $ 4950
- TOC Available:
-
Power SCADA Market by Architecture (Hardware, Software, Services), Component (Remote Terminal Unit, Programmable Logic Controller, Human Machine Interface, Communication Systems, Protection relays, MTU), End User and Region - Global Forecast to 2028
The power SCADA market is projected to reach USD 2.9 billion by 2028, a notable compound annual growth rate (CAGR) of 7.1% during the forecast period. Key players in the global power SCADA market include ABB (Switzerland), Rockwell Automation (US), Siemens (Germany), Schneider Electric (France), and Emerson (US).
- Published: January 2024
- Price: $ 4950
- TOC Available:
-
Edge Analytics Market by Component (Solutions and Services), Analytics Type, Business Application (Marketing, Sales, Operations, Finance, and Human Resources), Deployment, Vertical, and Region - Global Forecast to 2021
The edge analytics market is estimated to grow from USD 1.94 Billion in 2016 to USD 7.96 Billion by 2021, at a Compound Annual Growth Rate (CAGR) of 32.6%. Advent of Internet of Things (IoT) & proliferation of massive amount of data through connected devices, and predictive & real-time intelligence on network devices acts as a catalyst to the growing adoption of edge analytics solutions and services.
- Published: October 2016
- Price: $ 4950
- TOC Available:
-
Human Microbiome Market by Product (Drugs, Probiotics, Prebiotics, Synbiotics, Diagnostics), Disease (Infectious, Gastrointestinal), Route (Oral, Rectal), CDMO (Formulation, Strain Engineering), Type (BCT/FMT, Live Bacteria) - Global Forecast to 2031
The global human microbiome market, valued at US$0.91 billion in 2024, stood at US$1.40 billion in 2025 and is projected to advance at a resilient CAGR of 31.0% from 2025 to 2031, culminating in a forecasted valuation of US$7.09 billion by the end of the period. North American market held the largest share during the forecast period due to the rising investments by governments and industries, and presence of a strong human microbiome ecosystem supporting innovation in this field.
- Published: August 2025
- Price: $ 4950
- TOC Available:
Records 41 to 50 of 50
